- Calliditas Appoints New Chief Medical Officer
- Calliditas Strengthens its US Commercial Organization
- Calliditas Moves its Annual General Meeting 2020 to June 25
- Calliditas Therapeutics - Year-End Report 2019
- Positive Opinion Received From EMA Paediatric Committee on the Paediatric Investigation Plan for Nefecon for the Treatment of IgAN
- Calliditas Submits Draft Registration Statement for the Listing of ADSs in the U.S.
Calliditas Therapeutics AB (CALTX:STO) closed at 83.00, 92.35% above the 52 week low of 43.15 set on Apr 09, 2019.
43.15Apr 09 2019124.60Feb 07 2020
Markit short selling activity
|Market cap||3.33bn SEK|
|EPS (TTM)||-0.7567 |
Data delayed at least 15 minutes, as of Apr 07 2020 17:00 BST.